Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Feb 7, 2019 · 10-Q · 38 days after period end · 0001615774-19-002057
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$6.92M | -$4.06M | -$3.15M | -$3.95M |
| EPS Diluted | -$0.15 | -$0.09 | -$0.08 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Feb 7, 2019 · 38 d after period end
